Judith Trotman

58PUBLICATIONS
361CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedRegenerative medicine (incl. stem cells)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Jul 16, 2026
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial.

|Jul 16, 2026
Durable efficacy and manageable long-term safety of lisocabtagene maraleucel in 3L+ FL: 3-year update from TRANSCEND FL.

|Apr 14, 2026
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.

Vincent Camus, Daphné Krzisch, Alessio Bruscaggin

|Mar 31, 2026
Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.

Nicolas Gower, Pierre Feugier, Jason R Westin

|Mar 02, 2026
Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.

Jeff P Sharman, Luca Laurenti, Emmanuelle Ferrant

|Dec 22, 2025
Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (CAPITAL).

Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin

Pageof 10

Frequent Collaborators

16 joint publications

Emmanuel Bachy

16 joint publications

Samuel Griolet

16 joint publications

Guillaume Cartron

13 joint publications

Roch Houot